These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19699919

  • 1. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM.
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [Abstract] [Full Text] [Related]

  • 2. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
    Burdick MJ, Stephans KL, Reddy CA, Djemil T, Srinivas SM, Videtic GM.
    Int J Radiat Oncol Biol Phys; 2010 Nov 15; 78(4):1033-9. PubMed ID: 20472359
    [Abstract] [Full Text] [Related]

  • 3. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.
    J Thorac Cardiovasc Surg; 2008 Mar 15; 135(3):615-9. PubMed ID: 18329480
    [Abstract] [Full Text] [Related]

  • 4. Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?
    Iskender I, Kadioglu SZ, Kosar A, Atasalihi A, Kir A.
    Interact Cardiovasc Thorac Surg; 2011 Jun 15; 12(6):965-9. PubMed ID: 21441257
    [Abstract] [Full Text] [Related]

  • 5. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A.
    Thorax; 2007 Aug 15; 62(8):696-701. PubMed ID: 17687098
    [Abstract] [Full Text] [Related]

  • 6. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
    Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):e551-5. PubMed ID: 22417800
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM.
    J Nucl Med; 2007 Nov 15; 48(11):1761-6. PubMed ID: 17942814
    [Abstract] [Full Text] [Related]

  • 8. Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC).
    Kim SJ, Kim YK, Kim IJ, Kim YD, Lee MK.
    Radiother Oncol; 2011 Jan 15; 98(1):105-8. PubMed ID: 21159395
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
    Zhang H, Wroblewski K, Pu Y.
    Acta Radiol; 2012 Jun 01; 53(5):561-8. PubMed ID: 22661603
    [Abstract] [Full Text] [Related]

  • 10. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
    Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.
    J Clin Oncol; 2004 Aug 15; 22(16):3255-60. PubMed ID: 15310769
    [Abstract] [Full Text] [Related]

  • 11. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.
    Ann Thorac Surg; 2005 Jan 15; 79(1):263-8. PubMed ID: 15620955
    [Abstract] [Full Text] [Related]

  • 12. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S, Bilfinger TV, Komaroff E, Franceschi D.
    Clin Lung Cancer; 2005 Mar 15; 6(5):310-3. PubMed ID: 15845183
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD, Pryma DA, Xanthopoulos E, Kucharczuk J, Sterman D, Rengan R.
    Am J Clin Oncol; 2014 Apr 15; 37(2):135-9. PubMed ID: 23111361
    [Abstract] [Full Text] [Related]

  • 14. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS.
    J Clin Oncol; 2005 Nov 20; 23(33):8362-70. PubMed ID: 16293866
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy.
    Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R.
    J Radiat Res; 2010 Nov 20; 51(4):465-71. PubMed ID: 20508373
    [Abstract] [Full Text] [Related]

  • 16. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
    Kim SJ, Chang S.
    Oncol Res Treat; 2015 Nov 20; 38(11):577-85. PubMed ID: 26599271
    [Abstract] [Full Text] [Related]

  • 17. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 20; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 18. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ, Gee NG, Chino JP, D'Amico TA, Ready NE, Coleman RE, Kelsey CR.
    J Thorac Cardiovasc Surg; 2013 Oct 20; 146(4):796-801. PubMed ID: 23870158
    [Abstract] [Full Text] [Related]

  • 19. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
    Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA.
    Interact Cardiovasc Thorac Surg; 2010 Feb 20; 10(2):200-3. PubMed ID: 19933240
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Feb 20; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.